# Lilly Eli & Co: insider transactions

SEC CIK 59478. Roles and transactions as reported on Form 4. Latest Form 4 filed 2014-11-12.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Coherus Oncology, Inc.](/companies/chrs.md) | Former 10% Owner | 5 | 2014-11-12 | 2014-11-12 |
| [Dare Bioscience, Inc.](/companies/dare.md) | 10% owner | 9 | 2014-04-15 | 2014-04-15 |

## Transactions: 14

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C), derivative | 543,101 | not reported | not reported | [Form 4](/filings/0001209191-14-067900.md) |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C), derivative | 2,333,955 | not reported | not reported | [Form 4](/filings/0001209191-14-067900.md) |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Purchase (P) | 164,963 | $13.50 | $2.2m | [Form 4](/filings/0001209191-14-067900.md) |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C) | 543,101 | not reported | not reported | [Form 4](/filings/0001209191-14-067900.md) |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C) | 2,333,955 | not reported | not reported | [Form 4](/filings/0001209191-14-067900.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C), derivative | not reported | $0.00 | not reported | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C), derivative | not reported | $0.00 | not reported | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C), derivative | 4,340,831 | $0.00 | $0 | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C), derivative | 13,513,513 | $0.00 | $0 | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Purchase (P) | 733,445 | $7.00 | $5.1m | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C) | 199,875 | not reported | not reported | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C) | 192,209 | not reported | not reported | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C) | 299,213 | not reported | not reported | [Form 4](/filings/0001209191-14-027708.md) |
| 2014-04-15 | [Dare Bioscience, Inc.](/companies/dare.md) | Conversion (C) | 931,485 | not reported | not reported | [Form 4](/filings/0001209191-14-027708.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 01:31 ET. No prices; not investment advice.